Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

CT26 multi-tissue RNA-seq under immunotherapy combinations

ABSTRACT: Bulk RNA-seq profiling of CT26-bearing BALB/c mice across spleen, tumor, and tumor draining lymph node under multiple treatment regimens (Isotype, PD1, CYTO, PD1/CYTO, TS/CYTO, TS/PD1/CYTO) at study days 16 and 23.

ORGANISM(S): Mus musculus

PROVIDER: GSE342349 | GEO | 2026/08/04

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

RNA-Seq analysis of SUN1 knockout and control CT26 cells and tumors

Project description:T cell infiltration is essential for immune checkpoint inhibitors to be effective in treating solid cancers. Through a bioinformatic pipeline, we identified a target gene SUN1 that might relate to modulating immune cell infiltration and immune response. Thus, we generated one Sun1_knockout CT26 cell line (Sun1_KO) and two control CT26 cell lines (Sun1_Control) using CRISPR-Cas9. By performing RNA-seq on cultured cells, tumors grown in syngeneic model, and purified tumor cells from tumors grown in syngeneic model, we set out to understand how mouse Sun1 can affect immune-related pathways and immune cell infiltration and anti-PD1 efficacy in BALB/c mice.

2024-03-29 | GSE250602 | GEO

PF-07104091 (Tagtociclib) oral gavage on tumor and draining lymph node T cell transcriptomes

Project description:10x scRNA-seq of T cells collecting from the tumors and draining lymph nodes of the CT26 tumor-bearing BALB/c mice treated with either Vehicle or PF-07104091 for 7 days

2026-09-28 | GSE277110 | GEO

RNA-seq of CT26 subcutaneous tumors expressing control or Gna13 targeting sgRNAs

Project description:CT26 cells expressing lentiviral Cas9 and sgRNAs targeting either control or Gna13 were transplanted into immunocompetent BALB/c mice. Tumors were harvested and processed for RNA-seq

2021-10-01 | E-MTAB-10737 | biostudies-arrayexpress

CT26 sorted in vivo tumor cells with Trex1 KO

Project description:The DNA exonuclease TREX1 degrades endogenous cytosolic DNA. Cytosolic DNA triggers the cGAS/STING pathway which increases type I interferon. To investigate the physiological significance of TREX1 loss on in vivo tumor growth, we implanted control and TREX1-deficient CT26 tumor cells into immunocompetent BALB/c hosts.Tumor cells were collected 7 days after tumors reached around 200mm3.

2024-03-12 | E-MTAB-13816 | biostudies-arrayexpress

Project description:ct26-vector-isotype

| PRJNA826731 | ENA

Project description:ct26-pole-isotype

| PRJNA826718 | ENA

TCR variable regions transcripts of CT26-shppp2r1a and CT26-scr samples

Project description:TCR variable regions transcripts of three CT26-shppp2r1a samples and three CT26-scr samples

2021-11-20 | GSE189092 | GEO

Transcriptomic profiling of CT26 tumor-bearing mice treated with novel HDAC inhibitor GNTbm-38

Project description:Histone deacetylase inhibitors (HDACis) represent a promising therapeutic strategy in cancer treatment. In this study, we evaluated the therapeutic efficacy and molecular mechanisms of GNTbm-38, a novel HDAC inhibitor, using a syngeneic CT26 colon carcinoma tumor-bearing mouse model. BALB/c mice bearing subcutaneous CT26 tumors were treated with vehicle control or GNTbm-38. Bulk RNA-sequencing was performed on tumor tissues to characterize transcriptomic alterations induced by GNTbm-38. This dataset provides comprehensive gene expression profiles to elucidate the antitumor and immunomodulatory pathways regulated by GNTbm-38 in colorectal cancer.

2026-09-17 | GSE347712 | GEO

CT26 multi-tissue RNA-seq under immunotherapy combinations

Project description:CT26 multi-tissue RNA-seq under immunotherapy combinations

| PRJNA1507402 | ENA

CT26 RNA-Seq

Project description:RNA-Seq of CT26 mouse colorectal carcinoma and gene expression profiling

2014-02-07 | E-MTAB-2292 | biostudies-arrayexpress